Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Denis Monneret, Fouzi Mestari, Shaedah Djiavoudine, Guillaume Bachelot, Maxime Cloison, Françoise Imbert-Bismut, Maguy Bernard, Pierre Hausfater, Jean-Marc Lacorte & Dominique Bonnefont-Rousselot. (2018) Wide-range CRP versus high-sensitivity CRP on Roche analyzers: focus on low-grade inflammation ranges and high-sensitivity cardiac troponin T levels. Scandinavian Journal of Clinical and Laboratory Investigation 78:5, pages 346-351.
Read now
Read now
Mette Bjerre, Jørgen Hilden, Jens Kastrup, Maria Skoog, Jørgen F. Hansen, Hans J. Kolmos, Gorm B. Jensen, Erik Kjøller, Per Winkel, Allan Flyvbjerg & Christian Gluud. (2014) Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: The CLARICOR trial. Scandinavian Journal of Clinical and Laboratory Investigation 74:8, pages 657-664.
Read now
Read now
Josef Yayan. (2013) Emerging families of biomarkers for coronary artery disease: inflammatory mediators. Vascular Health and Risk Management 9, pages 435-456.
Read now
Read now
Articles from other publishers (21)
Yue Zhou, Xiaojian Wang, Hongbo Yuan, Linke Wu, Bin Zhang, Xiaoxia Chen & Yafeng Zhang. (2023) Impact of recombinant human brain natriuretic peptide on emergency dialysis and prognosis in end-stage renal disease patients with type 4 cardiorenal syndrome. Scientific Reports 13:1.
Crossref
Crossref
Emilie Han, Monika Fritzer-Szekeres, Thomas Szekeres, Teresa Gehrig, Mariann Gyöngyösi & Jutta Bergler-Klein. (2022) Comparison of High-Sensitivity C-Reactive Protein vs C-reactive Protein for Cardiovascular Risk Prediction in Chronic Cardiac Disease. The Journal of Applied Laboratory Medicine 7:6, pages 1259-1271.
Crossref
Crossref
Ye-Xuan Cao, Sha Li, Hui-Hui Liu, Meng Zhang, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Qian Dong, Jing Sun, Ke-Fei Dou & Jian-Jun Li. (2022) Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein in Patients With Previous Myocardial Infarction. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
V.E. Vladimirsky, E.V. Vladimirsky, A.N. Lunina, A.D. Fesyun, A.P. Rachin, O.D. Lebedeva, M.Yu. Yakovlev & M.A. Tubekova. (2022) Molecular mechanisms of adaptive and therapeutic effects of physical activity in patients with cardiovascular diseases. Voprosy kurortologii, fizioterapii i lechebnoi fizicheskoi kul'tury 99:2, pages 69.
Crossref
Crossref
Denise Börzsei, Renáta Szabó, Alexandra Hoffmann, Attila Harmath, Judith Sebestyén, Jasmin Osman, Béla Juhász, Dániel Priksz, Csaba Varga & Anikó Pósa. (2021) Multiple Applications of Different Exercise Modalities with Rodents. Oxidative Medicine and Cellular Longevity 2021, pages 1-11.
Crossref
Crossref
Per Winkel, Janus Christian Jakobsen, Jørgen Hilden, Gorm Boje Jensen, Erik Kjøller, Ahmad Sajadieh, Jens Kastrup, Hans Jørn Kolmos, Kasper Karmark Iversen, Mette Bjerre, Anders Larsson, Johan Ärnlöv & Christian Gluud. (2020) Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial. BMJ Open 10:8, pages e033720.
Crossref
Crossref
Mette Bjerre, Jørgen Hilden, Per Winkel, Gorm Boje Jensen, Erik Kjøller, Ahmad Sajadieh, Jens Kastrup, Hans Jørn Kolmos, Anders Larsson, Johan Ärnlöv, Janus Christian Jakobsen & Christian Gluud. (2020) Serum osteoprotegerin as a long-term predictor for patients with stable coronary artery disease and its association with diabetes and statin treatment: A CLARICOR trial 10-year follow-up substudy. Atherosclerosis 301, pages 8-14.
Crossref
Crossref
Jakob Schroder, Janus Christian Jakobsen, Per Winkel, Jørgen Hilden, Gorm Boje Jensen, Ahmad Sajadieh, Anders Larsson, Johan Ärnlöv, Marina Harutyunyan, Julia S. Johansen, Erik Kjøller, Christian Gluud & Jens Kastrup. (2020) Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease. Journal of the American Heart Association 9:5.
Crossref
Crossref
Kelsey Pinckard, Kedryn K. Baskin & Kristin I. Stanford. (2019) Effects of Exercise to Improve Cardiovascular Health. Frontiers in Cardiovascular Medicine 6.
Crossref
Crossref
Per Winkel, Janus Christian Jakobsen, Jørgen Hilden, Gorm Jensen, Erik Kjøller, Ahmad Sajadieh, Jens Kastrup, Hans Jørn Kolmos, Anders Larsson, Johan Ärnlöv & Christian Gluud. (2018) Prognostic value of routinely available data in patients with stable coronary heart disease. A 10-year follow-up of patients sampled at random times during their disease course. Open Heart 5:2, pages e000808.
Crossref
Crossref
Per Winkel, Janus Christian Jakobsen, Jørgen Hilden, Theis Lange, Gorm Boje Jensen, Erik Kjøller, Ahmad Sajadieh, Jens Kastrup, Hans Jørn Kolmos, Anders Larsson, Johan Ärnlöv & Christian Gluud. (2017) Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial. Diagnostic and Prognostic Research 1:1.
Crossref
Crossref
Umberto Barbero, Fabrizio D’Ascenzo, Freek Nijhoff, Claudio Moretti, Giuseppe Biondi-Zoccai, Marco Mennuni, Davide Capodanno, Marco Lococo, Michael J. Lipinski & Fiorenzo Gaita. (2016) Assessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME Era. Scientifica 2016, pages 1-10.
Crossref
Crossref
Viviana Brito, Andrea Alcaraz, Federico Augustovski, Andrés Pichón-Riviere, Sebastián García-Martí, Ariel Bardach, Agustín Ciapponi, Analía Lopez & Daniel Comandé. (2015) Proteína C ultrasensible como factor independiente de riesgo en población con y sin antecedentes cardiovasculares. Archivos de Cardiología de México 85:2, pages 124-135.
Crossref
Crossref
Per Winkel, Jørgen Hilden, Jørgen Fischer Hansen, Jens Kastrup, Hans Jørn Kolmos, Erik Kjøller, Gorm Boje Jensen, Maria Skoog, Jane Lindschou & Christian Gluud. (2015) Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial. International Journal of Cardiology 182, pages 459-465.
Crossref
Crossref
Naja Dam Mygind & Jens Kastrup. 2015. General Methods in Biomarker Research and their Applications. General Methods in Biomarker Research and their Applications
783
810
.
M. Volpe, S. Rubattu & J. Burnett. (2013) Natriuretic peptides in cardiovascular diseases: current use and perspectives. European Heart Journal 35:7, pages 419-425.
Crossref
Crossref
Martin Huth Ruwald, Jens Peter Goetze, Jan Bech, Olav Wendelboe Nielsen, Bente Kühn Madsen, Lars Bo Nielsen, Mette Mouridsen, Anne-Christine Huth Ruwald, Jan Kyst Madsen & Sune Pedersen. (2012) NT-ProBNP Independently Predicts Long-Term Mortality in Patients Admitted for Coronary Angiography. Angiology 65:1, pages 31-36.
Crossref
Crossref
Naja Dam Mygind & Jens Kastrup. 2014. General Methods in Biomarker Research and their Applications. General Methods in Biomarker Research and their Applications
1
22
.
Marina Harutyunyan, Jens P. Gøtze, Per Winkel, Julia S. Johansen, Jørgen Fischer Hansen, Gorm Boje Jensen, Jørgen Hilden, Erik Kjøller, Hans J. Kolmos, Christian Gluud & Jens Kastrup. (2013) Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: A prognostic study within the CLARICOR trial. Immunobiology 218:7, pages 945-951.
Crossref
Crossref
Marina Harutyunyan, Michael Christiansen, Julia S. Johansen, Lars Køber, Christian Torp-Petersen & Jens Kastrup. (2012) The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure. Immunobiology 217:6, pages 652-656.
Crossref
Crossref
Jens Kastrup. (2012) Can YKL-40 be a new inflammatory biomarker in cardiovascular disease?. Immunobiology 217:5, pages 483-491.
Crossref
Crossref